D. Boral Capital analyst Jason Kolbert initiated coverage of Nano-X Imaging (NNOX) with a Buy rating and $23 price target Nanox is at the forefront of transforming medical imaging with its disruptive Nanox.ARC technology, promising to make diagnostic imaging universally accessible, the analyst tells investors in a research note. The firm says Nanox delivers a cost-effective, compact, and scalable solution to address critical gaps in global healthcare.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NNOX:
- Nano X call volume above normal and directionally bullish
- Unusually active option classes on open January 3rd
- Nano-X Imaging Secures Shareholder Approval for Key Proposals
- Largest borrow rate increases among liquid names
- Nano-X Imaging’s (NNOX) Shares Surge on FDA Approval but Have Yet to Reach Profitability